Manisha Raja, Dermatology Account Manager at LEO Pharma and winner of the Secondary Care...
Congratulations on your Pf Award win Manisha, how did it feel when your name was announced? Thank you! My jaw dropped when my name was...
BD and iTS Leadership demonstrate how honesty and an appetite to solve problems can...
Tracey Clarke
HR Director for UK/Ireland and the Nordic region, BD, on how to create a no-blame culture of continuous learning. What is BD? BD is a...
Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who...
Novel gene therapy shows promise Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who suffer from an incurable skin...
Consilient Health’s Ian Sampson on the importance of traditional sales skills in an evolving...
More than ever, we are adopting new and innovative ways to communicate, and pharma is no different. Whilst traditional sales skills are just as...
eDetailing: Where are we in 2018?
Words by Dr Andrée Bates Detailing remains a core part of any pharmaceutical company’s sales approach and has become a large part of their promotional...
How can pharma harness the power of data to inform its scientific communications strategy?
Words by Simon Mason
Navigating the fast-changing healthcare data landscape is becoming increasingly challenging for pharma, owing to issues such as the rapid growth of...
Foreseeable future: MSD’s focus on emerging talent
Adelina Ismail
Role: Graduate Brand and Customer Manager, Vaccines & Women’s Health
Degree: BSc Marketing Management (Hons), Lancaster University
2-year graduate scheme: First year as a junior brand...
Gaining access: For products to commercially succeed it’s about what and who you know
Words by Andreas Knight
Many consider market access as a new component of commercial pharma, but in reality it has always been around in one...
2018: A pivotal year for outsourcing for Ashfield
Managing Director of Ashfield Commercial and Clinical UK, Colin Watson, talks about meeting changing industry demands, new innovations for a new year and why...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...